Skip to main content
Type at least 3 characters

1,371 articles

Original Research

Published on 23 Dec 2022

Vaccine-based clinical protection against SARS-CoV-2 infection and the humoral immune response: A 1-year follow-up study of patients with multiple sclerosis receiving ocrelizumab

in Multiple Sclerosis and Neuroimmunology

  • Saskia Räuber
  • Alice Willison
  • Melanie Korsen
  • Tristan Kölsche
  • Kristin S. Golombeck
  • Benedikt Plaack
  • Julia SchĂĽller
  • Niklas Huntemann
  • Leoni Rolfes
  • Christina B. Schroeter
Frontiers in Immunology
doi 10.3389/fimmu.2022.1037214
  • 3,737 views
  • 7 citations